These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8077929)

  • 1. A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves.
    van Engelenburg FA; Kaashoek MJ; Rijsewijk FA; van den Burg L; Moerman A; Gielkens AL; van Oirschot JT
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2311-8. PubMed ID: 8077929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.
    Kaashoek MJ; Rijsewijk FA; Ruuls RC; Keil GM; Thiry E; Pastoret PP; Van Oirschot JT
    Vaccine; 1998 May; 16(8):802-9. PubMed ID: 9627937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of bovine herpesvirus type 1 by deletion of its glycoprotein G and tk genes and protection against virulent viral challenge.
    Zhang M; Fu S; Deng M; Xie Q; Xu H; Liu Z; Hu C; Chen H; Guo A
    Vaccine; 2011 Nov; 29(48):8943-50. PubMed ID: 21959327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV.
    Taylor G; Rijsewijk FA; Thomas LH; Wyld SG; Gaddum RM; Cook RS; Morrison WI; Hensen E; van Oirschot JT; Keil G
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1759-67. PubMed ID: 9680140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants.
    Kaashoek MJ; van Engelenburg FA; Moerman A; Gielkens AL; Rijsewijk FA; van Oirschot JT
    Vet Microbiol; 1996 Jan; 48(1-2):143-53. PubMed ID: 8701570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A glycoprotein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissues in calves as wild-type virus, but for a shorter period.
    van Engelenburg FA; Kaashoek MJ; van Oirschot JT; Rijsewijk FA
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2387-92. PubMed ID: 7561782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and characterization of a glycoprotein E gene-deleted bovine herpesvirus type 1 recombinant.
    Chowdhury SI; Ross CS; Lee BJ; Hall V; Chu HJ
    Am J Vet Res; 1999 Feb; 60(2):227-32. PubMed ID: 10048557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of immunogenicity and virulence of bovine herpesvirus 1 mutants deficient in the UL49 homolog, UL49.5 homolog and dUTPase genes in cattle.
    Liang X; Chow B; Babiuk LA
    Vaccine; 1997 Jul; 15(10):1057-64. PubMed ID: 9269047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bovine herpesvirus type 1 (BHV-1) mutant lacking U(L)49.5 luminal domain residues 30-32 and cytoplasmic tail residues 80-96 induces more rapid onset of virus neutralizing antibody and cellular immune responses in calves than the wild-type strain Cooper.
    Wei H; He J; Paulsen DB; Chowdhury SI
    Vet Immunol Immunopathol; 2012 Jun; 147(3-4):223-9. PubMed ID: 22578851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and growth properties of bovine herpesvirus type 5 recombinants defective in the glycoprotein E or thymidine kinase gene or both.
    Brum MC; Weiblen R; Flores EF; Chowdhury SI
    Braz J Med Biol Res; 2010 Feb; 43(2):217-24. PubMed ID: 19893987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral replication and innate immunity of feline herpesvirus-1 virulence-associated genes in feline respiratory epithelial cells.
    Lee Y; Maes R; Tai SS; Soboll Hussey G
    Virus Res; 2019 Apr; 264():56-67. PubMed ID: 30796929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and pathogenic studies on a glycoprotein E variant field isolate of bovine herpesvirus 1.
    Egyed L; Ros C; Belák S
    Vet Res Commun; 2000 Sep; 24(6):423-31. PubMed ID: 11014611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine.
    Belknap EB; Walters LM; Kelling C; Ayers VK; Norris J; McMillen J; Hayhow C; Cochran M; Reddy DN; Wright J; Collins JK
    Vaccine; 1999 May; 17(18):2297-305. PubMed ID: 10403598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
    Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
    Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of latency associated with glycoprotein E (gE) seroconversion after bovine herpesvirus 1 infection in calves with high levels of passive antibodies lacking gE antibodies.
    Schynts F; Lemaire M; Ros C; Belak S; Thiry E
    Vet Microbiol; 2001 Sep; 82(3):211-22. PubMed ID: 11470543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of bovine herpesvirus-1 (BHV-1) recombinants which express pseudorabies virus (PRV) glycoproteins gB, gC, gD, and gE.
    Otsuka H; Xuan X
    Arch Virol; 1996; 141(1):57-71. PubMed ID: 8629951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bovine herpesvirus type 1 mutant virus specifying a carboxyl-terminal truncation of glycoprotein E is defective in anterograde neuronal transport in rabbits and calves.
    Liu ZF; Brum MC; Doster A; Jones C; Chowdhury SI
    J Virol; 2008 Aug; 82(15):7432-42. PubMed ID: 18480434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
    Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
    Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.
    Kalthoff D; König P; Trapp S; Beer M
    Vaccine; 2010 Aug; 28(36):5871-7. PubMed ID: 20600486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.